Skip to content
Home/Companies/Biotech/Provirex
Provirex

Provirex

Biotech·Germany·Active·4yr hold
Entry
2022
Hold
4yr
Status
Active

Who owns Provirex?

Provirex is currently owned by Bioventure Management through Bioventure Club Deals (2011 vintage), since 2022.

Hand-verified · updated 2026-08-10

Bioventure Management
Investor
Bioventure Management
Bioventure Club Deals · 2011 · Life Sciences VC

Key facts

HQGermany
SectorBiotech
StatusActive
Websiteprovirex.de

More from Bioventure Club Deals

Other portfolio companies in the same fund.

DiaMonTech
DiaMonTech
Active
MedTechGermany· 2025
Repairon
Repairon
Active
BiotechGermany· 2025
Aphaia Pharma
Active
PharmaSwitzerland· 2018
Aptarion Biotech
Aptarion Biotech
Active
BiotechGermany· 2017
Euroimmun
Exited 2017
MedTechGermany· 2013
to
Jennewein Biotechnologie
Exited 2020
BiotechGermany· 2012
to

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
GenSight Biologics
GenSight Biologics
Active
Sofinnova PartnersFrance
Healx
Healx
Active
Amadeus Capital PartnersUK
Track Provirex

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Provirex.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue